Indian gooseberry (emblica officinalis gaertn.)

Fruit and Vegetable Phytochemicals: Chemistry and Human Health: Second Edition

Volumn 2, Issue , 2017, Pages 1077-1105

  Pareek, Sunil ^a   Shikov, Alexander N ^b   Pozharitskaya, Olga N ^b   Makarov, Valery G ^b   González Aguilar, Gustavo A ^c   Ramalho, Suyare A ^d   Narain, Narendra ^d  

^a NATIONAL INSTITUTE OF FOOD TECHNOLOGY ENTREPRENEURSHIP AND MANAGEMENT   (India)

^b Saint Petersburg Institute of Pharmacy   (Russian Federation)

^c Research Center for Food and Development   (Mexico)

^d FEDERAL UNIVERSITY OF SERGIPE   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 85049710699     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1002/9781119158042.ch54     Document Type: Chapter

References (232)

1. Abete I, Goyenechea E, Zulet MA, Martinez JA. 2011. Obesity and metabolic syndrome: potential benefit from specific nutritional components. Nutr Metab Cardiovasc Dis, 21:B1-B15.
2. Achliya GS, Wadodkar SG, Dorle AK. 2004. Evaluation of hepatoprotective effect of Amalkdi Ghrita against carbon tetrachloride-induced hepatic damage in rats. J Ethnopharmacol, 90:229-232.
3. Adil MD, Kaiser P, Satti NK, Zargar AM, Vishwakarma RA, Tasduq SA. 2010. Effect of Emblica officinalis (fruit) against UVB-induced photo-aging in human skin fibroblasts. J Ethnopharmacol, 28:109-114.
4. Agarwal C, Tyagi A, Agarwal R. 2006. Gallic acid causes inactivating phosphorylation of cdc25A/cdc25C-cdc2 via ATM-Chk2 activation, leading to cell cycle arrest, and induces apoptosis in human prostate carcinoma DU145 cells. Mol Cancer Therap, 5:3294-3302.
5. Alam MI, Gomes A. 2003. Snake venom neutralization by Indian medicinal plants (Vitex negando and Emblica officinalis) root extracts. J Ethnopharmacol, 86:75-80.
6. Al-Rehaily AJ, Al Howiriny TA, Al Sohaibani MO, Rafatullah S. 2002. Gastroprotective effects of 'Amla' Emblica officinalis on in vivo test models in rats. Phytomed, 9:515-522.
7. Ammal EKJ, Bhaghawan RS. 1957. Physiology and vitamin C in Emblica officinalis. Proc Ind Acad Sci B, 47:312-334.
8. Anila L, Vijayalakshmi NL. 2003. Antioxidant action of flavonoids from Mangifera indica and Emblica officinalis in hypercholesterolemic rats. Food Chem, 83:569-574.
9. Anilakumar KR, Nagaraj NS, Santhanam K. 2007. Reduction of hexachlorocyclohexane-induced oxidative stress and cytotoxicity in rat liver by Emblica officinalis Gaertn. Ind J Exp Biol, 45:450-454.
10. Are C, Colbum L, Rajaram S, Vijayakumar M. 2010. Disparities in cancer care between the United States of America and India and opportunities for surgeons to lead. J Surg Onc, 102:100-105.
11. Aruoma OI. 1998. Free radicals, oxidative stress, and antioxidants in human health and disease. J Am Oil Chem Soc, 75:199-212.
12. Bafna PA, Balaraman R. 2005a. Anti-ulcer and anti-oxidant activity of pepticare, a herbomineral formulation. Phytomedicine, 12:264-270.
13. Bafna PA, Balaraman R. 2005b. Antioxidant activity of DHC-1, an herbal formulation, in experimentally- induced cardiac and renal damage. Phytother Res, 19:216-221.
14. Bailey LH. 1917. The Standard Cyclopedia of Horticulture. McMillan: London.
15. Bajpai PN. 1957. Blossom biology and fruit set in Phyllanthus emblica L. Ind J Hort, 14:99-102.
16. Banu SM, Selvendiran K, Singh JP, Sakthisekaran D. 2004. Protective effect of Emblica officinalis ethanolic extract against 7, 12-dimethylbenz[a]anthracene (DMBA) induced genotoxicity in Swiss albino mice. Hum Exp Toxicol, 23:527-531.
17. Barrett MF. 1956. Common Exotic Trees of South Florida. University of Florida Press: Gainesville, FL.
18. Barthakur NN, Arnold NP. 1991. Chemical analysis of the emblic (Phyllanthus emblica L.) and its potential as a food source. Sci Hort, 47:99-105.
19. Barwal VS, Garg V, Sharma R. 2010. Development and quality evaluation of aonla mouth freshner. J Food Sci Technol, 47:697-699.
20. Benkovic V, Knezevic A, Dikic D. 2009. Radioprotective effects of quercetin and ethanolic extract of propolis in gamma-irradiated mice. Arch Ind Hygiene Toxicol 60:129-138.
21. Benkovic V, Knezevic AH, Dikic D, Lisicic D, Orsolic N, Basic I. 2008a. Radioprotective effects of propolis and quercetin in gamma-irradiated mice evaluated by the alkaline comet assay. Phytomedicine, 15:851-858.
22. Benkovic V, Kopjar N, Knezevic AH, Dikic D, Basic I, Ramic S. 2008b. Evaluation of radioprotective effects of propolis and quercetin on human white blood cells in vitro. Biol Pharm Bull, 31:1778-1785.
23. Benthal AP. 1946. Trees of Calcutta and its Neighbourhood. Thacker Apink: Calcutta.
24. Bhattacharya A, Chatterjee A, Ghosal S, Bhattacharya SK. 1999. Antioxidant activity of active tannoid principles of Emblica officinalis (Amla). Ind J Exp Biol, 38:877-880.
25. Bhattacharya A, Kumar M, Ghosal S, Bhattacharya SK. 1999. Effect of bioactive tannoid principles of Emblica officinalis on iron-induced hepatic toxicity in rats. Phytomedicine, 7:173-175.
26. Bhattacharya SK, Bhattacharya A, Sairam K, Ghosal S. 2002. Effect of bioactive tannoid principles of Emblica officinalis on ischemia-reperfusion induced oxidative stress in rat heart. Phytomedicine, 9:171-174.
27. Bhosle S, Huilgol N, Mishra K. 2005. Enhancement of radiation induced oxidative stress and cytotoxicity in tumor cells by ellagic acid. Clin Chim Acta, 359:89-100.
28. Cai YZ, Sun M, Xing J, Luo Q, Corke H. 2006. Structure- radical scavenging activity relationships of phenolic compounds from traditional Chinese medicinal plants. Life Sci, 78:2872-2888.
29. Caltagirone S, Rossi C, Poggi A, et al. 2000. Flavonoids apigenin and quercetin inhibit melanoma growth and metastatic potential. Int J Cancer, 87:595-600.
30. Catania AS, de Barros CR, Ferreira SR. 2009. Vitamins and minerals with antioxidant properties and cardiometabolic risk: controversies and perspectives. Arq Bras Endocrinol Metabol, 53:550-589.
31. Chang R, Huang M, Wood A, et al. 1985. Effect of ellagic acid and hydroxylated flavonoids on the tumorigenicity of benzo[a]pyrene and (±)-7ß, 8a-dihydroxy-9a, 10a- epoxy-7, 8, 9, 10-tetrahydrobenzo[a]pyrene on mouse skin and in the newborn mouse. Carcinogenesis 6(8):1127-1133.
32. Charoenteeraboon J, Ngamkitidechakul C, Soonthornchareonnon N, Jaijoy K, Sireeratawong S. 2010. Antioxidant activities of the standardized water extract from fruit of Phyllanthus emblica Linn. Songklanakarin J Sci Technol, 32:599-604.
33. Chatterjee A, Chattopadhyay S, Sandip K, Bandyopadhyay B. 2011. Effect of Phyllanthus emblica L. extract on NSAID-induced ulcer: an antioxidative trail weaved with immunomodulatory effect. Evid Based Complement Alternat Med, 2011:ID146808. doi: 10.1155/2011/ 146808
34. Chaudhuri RK. 2002. Emblica cascading antioxidant: a novel natural skin care ingredient. Skin Pharmacol Appl Skin Physiol, 15:374-380.
35. Chauhan OP, Srivastava S, Pandey P, Rai GK. 2005. A study on the development of aonla blended sauce. Beverage Food World, 32:31-32.
36. Chen H, Wu Y, Chia Y. 2009. Gallic acid, a major component of Toona sinensis leaf extracts, contains a ROS mediated anti-cancer activity in human prostate cancer cells. Cancer Lett, 286:161-171.
37. Das M, Khan W, Asokan P. 1987. Inhibition of polycyclic aromatic hydrocarbon-DNA adduct formation in epidermis and lungs of SENCAR mice by naturally occurring plant phenols. Cancer Res, 47:767-773.
38. De S, Chakraborty J, Chakraborty R, Das S. 2000. Chemopreventive activity of quercetin during carcinogenesis in cervix uteri in mice. Phytother Res, 14:347-351.
39. De S, Chakraborty R, Ghosh S. 2004. Comparative evaluation of cancer chemopreventive efficacy of alphatocopherol and quercetin in a murine model. J Exp Clin Canc Res, 23:251-258.
40. Deep G, Dhiman M, Rao AR, Kale RK. 2005. Chemopreventive potential of Triphala (a composite Indian drug) on benzo[a]pyrene induced forestomach tumorigenesis in murine tumor model system. J Exp Clin Canc Res, 24:555-563.
41. Deka BC, Sethi V, Prasad R, Batra PK. 2001. Application of mixtures methodology for beverages from mixed fruit juice/pulp. J Food Sci Technol, 38:615-618.
42. Del B, Mukhtar H, Bickers D. 1983. Inhibition of epidermal metabolism and DNA-binding of benzo[a]pyrene by ellagic acid. Biochem Biophys Res Commun, 114:388-394.
43. Devasagayam TP, Tilak JC, Boloor KK, Sane KS, Ghaskadbi SS, Lele RD. 2004. Free radicals and antioxidants in human health: current status and future prospects. J Assoc Phys Ind, 52:794-804.
44. Dhanalakshmi S, Devi RS, Srikumar R, Manikandan S, Thangaraj R. 2007. Protective effect of Triphala on cold stress-induced behavioral and biochemical abnormalities in rats. Yakugaku Zasshi, 127:1863-1867.
45. Dhir H, Agarwal K, Sharma A, Talukder G. 1991. Modifying role of Phyllanthus emblica and ascorbic acid against nickel clastogenicity in mice. Cancer Lett, 26:9-18.
46. Dhir H, Roy AK, Sharma A, Talukdar G. 1990a. Protection afforded by aqueous extracts of Phyllanthus species against cytotoxicity induced by lead and aluminium salts. Phytother Res, 4:172-176.
47. Dhir H, Roy AK, Sharma A, Talukder G. 1990b. Modification of clastogenicity of lead and aluminium in mouse bone marrow cells by dietary ingestion of Phyllanthus emblica fruit extract. Mut Res, 241:305-312.
48. Doll R, Peto R. 1981. The causes of cancer: quantitative estimates of avoidable risks of cancer in the United States today. J Natl Cancer Inst, 66:1191-1308.
49. El-Mekkawy S, Meselhy MR, Kusumoto IT, Kadota S, Hattori M, Namba T. 1995. Inhibitory effects of Egyptian folk medicines on human immunodeficiency virus (HIV) reverse transcriptase. Chem Pharmaceut Bull, 43:641-648.
50. Ferlay J, Shin HR, Bray F, Forman D, Mathers C, Parkin DM. 2010. Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008. Int J Cancer, 127:2893-2917.
51. Fernandez MT, Mira ML, Florencio MH, Jennings KR. 2002. Iron and copper chelation by flavonoids: an electrospray mass spectrometry study. J Inorg Biochem, 92:105-111.
52. Finkel T, Holbrook NJ. 2000. Oxidants, oxidative stress and the biology of ageing. Nature, 408:239-247.
53. Fujii T, Wakaizumi M, Ikami T, Saito M. 2008. Amla (Emblica officinalis Gaertn.) extract promotes procollagen production and inhibits matrix metalloproteinase-1 in human skin fibroblasts. J Ethnopharmacol, 119:53-57.
54. Furtado R, Rodrigues E, Araujo F. 2008. Ursolic acid and oleanolic acid suppress preneoplastic lesions induced by 1, 2-dimethylhydrazine in rat colon. Toxicol Pathol, 36:576-580.
55. Gali H, Perchellet E, Klish D. 1992. Antitumor promoting activities of hydrolysable tannins in mouse skin. Carcinogenesis, 13:715-718.
56. Gandhi N, Nair C. 2005. Protection of DNA and membrane from gamma radiation induced damage by gallic acid. Mol Cell Biochem, 278:111-117.
57. Ganju L, Karan D, Chanda S, Srivastava KK, Sawhney RC, Selvamurthy W. 2003. Immunomodulatory effects of agents of plant origin. Biomed Pharmacother, 57:296-300.
58. Ghosal S, Tripathi VK, Chauhan S. 1996. Active constituents of Emblica officinalis: Part I. The chemistry and antioxidant activity of two new hydrolysable tannins, emblicanin A and B. Ind J Chem, 35:941-948.
59. Ghosh A, Sharma A, Talukder G. 1992. Relative protection given by extract of Phyllanthus emblica fruit and an equivalent amount of vitamin C against a known clastogen: caesium chloride. Food Chem Toxicol, 30:865-869.
60. Gillman MW, Cupples LA, Gagnon D, Posner BM, Ellisor Castelli WP, Wolf PA. 1995. Protective effect of fruit and vegetables on development of stroke in men. J Am Med Assoc, 273:1113-1117.
61. Gongye LHY. 1987. Constituents in aonla seed and bark. Chem Abs, 7:20.
62. Goyal RK, Patil RT, Kingsly ARP, Walia H, Kumar P. 2008. Status of postharvest technology of aonla in India: a review. Am J Food Technol, 3:13-23.
63. Gupta M, Shaw BP, Mukherjee A. 2008a. Evaluation of antipyretic effect of a traditional polyherbal preparation: a double blind, randomized clinical trial. Int J Pharmacol, 4:190-195.
64. Gupta M, Shaw BP, Mukherjee A. 2008b. Studies on antipyretic-analgesic and ulcerogenic activity of polyherbal preparation in rats and mice. Int J Pharmacol, 4:88-94.
65. Hanif M, Rahman J, Ahmed I, Bhatty MK, Karimullah. 1966. The antioxidant factor of aonla fruit. J Res, 18:61-63.
66. Haque R, Bin-Hafeez B, Ahmad I, Parvez S, Pandey S, Raisuddin S. 2001. Protective effects of Emblica officinalis Gaertn. in cyclophosphamide treated mice. Hum Exp Toxicol, 20:643-650.
67. Hari Kumar KB, Kuttan A. 2004. Protection effect of an extract of Phyllanthus amarus against radiation-induced damage in mice. J Radiat Res, 45:133-139.
68. Hazra B, Sarkar R, Biswas S, Mandal N. 2010. Comparative study of the antioxidant and reactive oxygen species scavenging properties in the extracts of the fruits of Terminalia chebula, Terminalia bellirica and Emblica officinalis. BMC Comp Alt Med, 10:1-15.
69. Hooker JD. 1937. The Flora of British India, vol. V. Periodical Experts: Delhi.
70. Hooper D, Field H. 1937. Useful Plants and Drugs of Iran and Iraq. Publication 387, Botany Series. Field Museum of Natural History: Chicago.
71. Ingkatawornwong S, Sakdiset P, Kaew-on P, Nobnob N, Pinsuwan S. 2008. Antioxidant evaluation and liposome formulation of Phyllanthus emblica extract. Planta Med, 74(9). doi: 10.1055/s-0028-1084554
72. Jain SK, Khurdiya DS. 2004. Vitamin C enrichment of fruit juice based ready-to-serve beverages through blending of Indian gooseberry (Emblica officinalis Gaertn.) juice. Plant Foods Hum Nutr, 59:63-66.
73. Jeena KJ, Joy KL, Kuttan R. 1999. Effect of Emblica officinalis, Phyllanthus amarus and Picrorhiza kurroa on N-nitrosodiethylamine induced hepatocarcinogenesis. Cancer Lett, 136:11-16.
74. Jenkins DJA, Kendall CWC, Ransom TPP. 1998. Dietary fiber, the evolution of the human diet and coronary heart disease. Nutr Res, 18:633-652.
75. Jeong J, Kim M, Kim T. 2009. Kaempferol induces cell death through ERK and Akt-dependent downregulation of XIAP and surviving in human glioma cells. Neurochem Res, 34:991-1001.
76. Ji BC, Hsu WH, Yang JS, Hsia TC, Lu CC, Chiang JH. 2009. Gallic acid induced apoptosis via caspase-3 and mitochondrion-dependent pathways in vitro and suppresses lung xenograft tumor growth in vivo. J Agric Food Chem, 57:7596-7604.
77. Jose JK, Kuttan R. 2000. Hepatoprotective activity of Emblica officinalis and Chyavanaprash. J Ethnopharmacol, 72:135-140.
78. Jose JK, Kuttan G, George J, Kuttan R. 1997. Antimutagenic and anticarcinogenic activity of Emblica officinalis Gaertn. J Clin Biochem Nutr, 22:171-176.
79. Jose JK, Kuttan R, Bhattacharya RK. 1998. Effect of Emblica officinalis on hepatocarcinogenesis and carcinogen metabolism. J Clin Biochem Nutr, 25:31-39.
80. Joseph J, Kuttan R. 2011. Anticancer activity of Phyllanthus emblica. In: Kuttan R, Harikumar KB, Eds., Phyllanthus Species: Scientific Evaluation and Medicinal Applications, pp. 183-192. CRC Press: Boca Raton, FL.
81. Jung S, Lee K, Byun S. 2008. Myricetin suppresses UVB- induced skin cancer by targeting Fyn. Cancer Res, 68:6021-6029.
82. Kamal R, Yadav S, Mathur M, Katariya P. 2012. Antiradical efficiency of 20 selected medicinal plants. Nat Prod Res, 26:1054-1062.
83. Kang W, Kim JH, Song K, Kim SH, Yoon JH, Kim KS. 2010. Kaempferol and quercetin components of Ginkgo biloba extract (EGb 761), induce caspase-3-dependent apoptosis in oral cavity cancer cells. Phytother Res, 24: S77-S82.
84. Kapoor LD. 1990. Handbook of Ayurvedic Medicinal Plants. CRC Press: Boca Raton, FL.
85. Kaul A, Khanduja K. 1998. Polyphenols inhibit promotional phase of tumorigenesis: relevance of superoxide radicals. Nutr Cancer, 32:81-85.
86. Kaur M, Velmurugan B, Rajamanickam S. 2009. Gallic acid, an active constituent of grape seed extract, exhibits anti proliferative, proapoptotic and antitumorigenic effects against prostate carcinoma genograft growth in nude mice. Pharmaceut Res, 26:2133-2140.
87. Kaur S, Arora S, Kaur K, Kumar S. 2002. The in vitro antimutagenic activity of Triphala: an Indian herbal drug. Food Chem Toxicol, 40:527-534.
88. Kaur S, Michael H, Arora S, Härkönen PL, Kumar S. 2005. The in vitro cytotoxic and apoptotic activity of Triphala: an Indian herbal drug. J Ethnopharmacol, 97:15-20.
89. Khan AS, Hussain A, Khan F. 2006. Nutritional importance of micronutrients in some edible wild and unconventional fruits. J Chem Soc Pak, 28:576-582.
90. Khan KH. 2009. Roles of Emblica officinalis in medicine: a review. Bot Res Int, 2:218-228.
91. Khan MT, Lampronti I, Martello D, et al. 2002. Identification of pyrogallol as an antiproliferative compound present in extracts from the medicinal plant Emblica officinalis: effects on in vitro cell growth of human tumor cell lines. Int J Onc, 21:187-192.
92. Khanduja K, Gandhi R, Pathania V. 1999. Prevention of N-nitrosodiethylamine-induced lung tumorigenesis by ellagic acid quercetin in mice. Food Chem Toxicol, 37:313-318.
93. Khopde SM, Indira Priyadarsini K, Mohan H, et al. 2001. Characterizing the antioxidant activity of Amla (Phyllanthus emblica) extract. Curr Sci, 81:185-190.
94. Kim HJ, Yokozawa T, Kim HY, Tohda C, Rao TP, Juneja LR. 2005. Influence of Amla (Emblica officinalis Gaertn.) on hypercholesterolemia and lipid peroxidation in cholesterol-fed rats. J Nutr Sci Vitaminol, 51:413-418.
95. Kim HY, Okubo T, Juneja LR, Yokozawa T. 2010. The protective role of Amla (Emblica officinalis Gaertn.) against fructose-induced metabolic syndrome in a rat model. Br J Nutr, 103:502-512.
96. King GL, Loeken MR. 2004. Hyperglycaemia induced oxidative stress in diabetic complications. Histochem Cell Biol, 122:333-338.
97. Krishnaveni M, Mirunalini S. 2012. Chemopreventive efficacy of Phyllanthus emblica L. (Amla) fruit extract on 7, 12-dimethylbenz[a]anthracene induced oral carcinogenesis: a dose response study. Environ Toxicol Pharmacol, 34:801-810.
98. Kubola J, Siriamornpun S, Meeso N. 2011. Phytochemicals, vitamin C and sugar content of Thai wild fruits. Food Chem, 126:972-981.
99. Kumar A, Singh A, Dora J. 2012. Essential perspectives for Emblica officinalis. Int J Pharm Chem Sci, 1:1-18.
100. Kumar A, Tantry BA, Rahiman S, Gupta U. 2011. Comparative study of antimicrobial activity and phytochemical analysis of methanolic and aqueous extracts of the fruit of Emblica officinalis against pathogenic bacteria. J Trad Chinese Med, 31:246-250.
101. Kumar GS, Nayaka H, Dharmesh SM, Salimath PV. 2006. Free and bound phenolic antioxidants in Amla (Emblica officinalis) and turmeric (Curcuma longa). J Food Compos Anal, 19:446-452.
102. Kumar NP, Annamalai AR, Thakur RS. 2009. Antinociceptive property of Emblica officinalis Gaertn. (Amla) in high fat diet-fed/low dose streptozotocin induced diabetic neuropathy in rats. Ind J Exp Biol, 47:737-742.
103. Kumar N, Rungseevijitprapa W, Narkkhong N, Suttajit M, Chaiyasuta C. 2012. 5a-Reductase inhibition and hair growth promotion of some Thai plants traditionally used for hair treatment. J Ethnopharmacol, 139:765-771.
104. Kumaran A, Karunakaran RJ. 2006. Nitric oxide radical scavenging active components from Phyllanthus emblica L. Plant Foods Hum Nutr, 61:1-5.
105. Kuo S. 1996. Antiproliferative potency of structurally distinct dietary flavonoids on human colon cancer cells. Cancer Lett, 110:41-48.
106. Lambertini E, Piva R, Khan MT, et al. 2004. Effect of extracts from Bangladeshi medicinal plants on in vitro proliferation of human breast cancer cell lines and expression of estrogen receptor alpha gene. Int J Onc, 24:419-423.
107. Lee K, Lee D, Seo S. 2010. Phosphatidylinositol 3-kinase, a novel target molecule for the inhibitory effects of kaempferol on neoplastic cell transformation. Carcinogen, 31:1338-1343.
108. Lesca P. 1983. Protective effects of ellagic acid and other plant phenols on benzo[a]pyrene-induced neoplasia in mice. Carcinogen, 4:1651-1653.
109. Li W, Du B, Wang T. 2009. Kaempferol induces apoptosis in human HCT116 colon cancer cells via the ataxia telangiectasia mutated-p53 pathway with the involvement of p53 upregulated modulators of apoptosis. Chem Biol Interact, 177:121-127.
110. Liu G, Xiong S, Xiang S, et al. 2011. Antiviral activity and possible mechanisms of action of pentagalloylglucose (PGG) against influenza A virus. Arch Virol, 156:1359-1369.
111. Liu RH. 2004. Potential synergy of phytochemicals in cancer prevention: mechanism of action. J Nutr, 134:3479S-3485S.
112. Liu X, Cui C, Zhao M, et al. 2008a. Identification of phenolics in the fruit of Emblica (Phyllanthus emblica L.) and their antioxidant activities. Food Chem 109:909-915.
113. Liu X, Zhao M, Wang J, Yang B, Jiang Y. 2008b. Antioxidant activity of methanolic extract of Emblica fruit (Phyllanthus emblica L.) from six regions in China. J Food Compos Anal, 21:219-228.
114. Liu X, Zhao M, Wu K, et al. 2012. Immunomodulatory and anticancer activities of phenolics from Emblica fruit (Phyllanthus emblica L.). Food Chem, 131:685-690.
115. Lo C, Lai T, Yang J. 2010. Gallic acid induces apoptosis in A375. S2 human melanoma cells through caspase- dependent and -independent pathways. Int J Onc, 37:377-385.
116. Luo W, Wen L, Zhao M, et al. 2012. Structural identification of isomallotusinin and other phenolics in Phyllanthus emblica L. fruit hull. Food Chem, 132:1527-1533.
117. Luo W, Zhao M, Yang B, Ren J, Shen G, Rao G. 2011. Antioxidant and antiproliferative capacities of phenolics purified from Phyllanthus emblica L. fruit. Food Chem, 26:277-282.
118. Luo W, Zhao M, Yang B, Shen G, Rao G. 2009. Identification of bioactive compounds in Phyllanthus emblica L. fruit and their free radical scavenging activities. Food Chem, 114:499-504.
119. Luqman S, Kaushik S, Srivastava S, et al. 2009. Protective effect of medicinal plant extracts on biomarkers of oxidative stress in erythrocytes. Pharma Biol, 47:483-490.
120. MacMillan HF. 1943. Tropical Planting and Gardening with Special Reference to Ceylon, 5th edn. MacMillan: New Delhi, India.
121. Madhuri S. 2008. Studies on estrogen induced uterine and ovarian carcinogenesis and effect of prolmmu in rat. PhD Thesis, RDVV, Jabalpur, Madhya Pradesh, India.
122. Majeed M, Bhat B, Jadhav AN, Srivastava JS, Nagabhushanam K. 2009. Ascorbic acid and tannins from Emblica officinalis Gaertn. fruits: a revisit. J Agric Food Chem, 57:220-225.
123. Makita H, Tanaka T, Fujitsuka H. 1996. Chemoprevention of 4-nitroquinoline 1-oxide-induced rat oral carcinogenesis by the dietary flavonoids chalcone, 2-hydroxychalcone, and quercetin. Cancer Res, 56:4904-4909.
124. Mathur R, Sharma A, Dixit VP, Varma M. 1996. Hypolipidaemic effect of fruit juice of Emblica officinalis in cholesterol-fed rabbits. J Ethnopharmacol, 50:61-68.
125. Mayachiew P, Devahastin S. 2008. Antimicrobial and antioxidant activities of Indian gooseberry and galangal extracts. LWT - Food Sci Technol, 41:1153-1159.
126. 2+ channels. J Ethnopharmacol, 133:856-865.
127. Mehta S, Singh RK, Jaiswal D, Rai PK, Watal G. 2009. Anti diabetic activity of Emblica officinalis in animal models. Pharm Biol, 47:1050-1055.
128. Mishra M, Pathak UN, Khan AB. 1981. Emblica officinalis Gaertn. and serum cholesterol level in experimental rabbits. Br J Exp Pathol, 62:526-528.
129. Mishra P, Srivastava V, Verma D, Chauhan OP, Rai GK. 2009. Physico-chemical properties of Chakaiya variety of Amla (Emblica officinalis) and effect of different dehydration methods on quality of powder. Afr J Food Sci, 3:303-306.
130. Mukhtar H, Das M, Bickers D. 1986. Inhibition of 3- methylcholanthrene-induced skin tumorigenicity in BALB/C mice by chronic oral feeding of trace amounts of ellagic acid in drinking water. Cancer Res, 46:2262-2265.
131. Mukhtar H, Das M, Del B. 1984a. Protection against 3- methylcholanthrene-induced skin tumorigenesis in BALB/C mice by ellagic acid. Biochem Biophys Res Commun, 119:751-757.
132. Mukhtar H, Del B, Marcelo C. 1984b. Ellagic acid: a potential naturally occurring inhibitor of benzo[a]pyrene metabolism and its subsequent glucuronidation, sulphation and covalent binding to DNA in cultured BALB/C mouse karatinocytes. Carcinogenesis, 5:1565-1571.
133. Muruganandam AV, Kumar V, Bhattacharya SK. 2002. Effect of poly herbal formulation, EuMil, on chronic stress-induced homeostatic perturbations in rats. Ind J Exp Biol, 40:1151-1160.
134. Naik GH, Priyadarsini KI, Bhagirathi RG, et al. 2005. In vitro antioxidant studies and free radical reactions of Triphala, an Ayurvedic formulation and its constituents. Phytother Res, 19:582-586.
135. Nain P, Saini V, Sharma S, Nain J. 2012. Antidiabetic and antioxidant potential of Emblica officinalis Gaertn. leaves extract in streptozotocin-induced type 2 diabetes mellitus (T2DM) rats. J Ethnopharmacol, 142:65-71.
136. Nair H, Rao K, Aalinkeel R. 2004. Inhibition of prostate cancer cell colony formation by the flavonoid quercetin correlation with modulation of specific regulatory genes. Clin Diagn Lab Immunol, 11:63-69.
137. Nampoothiri SV, Prathapan A, Cherian OL, Venugopalan VV, Sundaresan A. 2011. In vitro antioxidant and inhibitory potential of Terminalia bellirica and Emblica officinalis fruits against LDL oxidation and key enzymes linked to type 2 diabetes. Food Chem Toxicol, 49:125-131.
138. Nemavarkar P, Chourasia VK, Pasupathy K. 2004. Evaluation of radioprotective action of compounds using Saccharomyces cerevisiae. J Environ Pathol Toxicol Oncol, 23:145-151.
139. Nosál'ová G, Mokrý J, Hassan KM. 2003. Antitussive activity of the fruit extract of Emblica officinalis Gaertn. (Euphorbiaceae). Phytomedicine, 10:583-589.
140. Panchabhai TS, Ambarkhane SV, Joshi AS, Samant BD, Rege NN. 2008. Protective effect of Tinospora cordifolia, Phyllanthus emblica and their combination against antitubercular drugs induced hepatic damage: an experimental study. Phytother Res, 22:646-650.
141. Panda S, Kar A. 2003. Fruit extract of Emblica officinalis ameliorates hyperthyroidism and hepatic lipid peroxidation in mice. Pharmazie, 58:753-755.
142. Pandey G. 2011. Some important anticancer herbs: a review. Int Res J Pharm, 2:45-52.
143. Panriansaen R, Cherdshewasart W, Subtang S. 2008. The Thai medicinal plants used in traditional rejuvenating medicines exhibit potent antioxidant activity. Planta Med, 74:PF11. doi: 10.1055/s-0028-1084739
144. Pareek S, Kaushik RA. 2012. Effect of drying methods on quality of Indian gooseberry (Emblica officinalis Gaertn.) powder during storage. J Sci Ind Res, 71:727-732.
145. Patel SS, Shah RS, Goyal RK. 2009. Antihyperglycemic, antihyperlipidemic and antioxidant effects of Dihar, a polyherbal Ayurvedic formulation in streptozotocin induced diabetic rats. Ind J Exp Biol, 47:564-570.
146. Pathak RK. 2003. Status Report on Genetic Resources of Indian Gooseberry Aonla (Emblica officinalis Gaertn.) in South and South East Asia. IPGRI Office for South Asia: New Delhi, India.
147. Pathak RK, Srivastava AK, Diwedi R, Singh HK. 1993. Aonla Descriptor, pp. 1-24. Department of Horticulture, N.D. University of Agriculture and Technology, Faizabad, Uttar Pradesh. India.
148. Patil SG, Desmukh AA, Padol AR, Kale DB. 2012. In vitro antibacterial activity of Emblica officinalis fruit extract by tube dilution method. Int J Toxicol App Pharmacol, 2:49-51.
149. Perianayagam JB, Narayanan S, Gnanasekar G, et al. 2005. Evaluation of antidiarrheal potential of Emblica officinalis Gaertn. Pharm Biol, 43:373-377.
150. Perianayagam JB, Sharma SK, Joseph A, Christina AJ. 2004. Evaluation of anti-pyretic and analgesic activity of Emblica officinalis Gaertn. J Ethnopharmacol, 95:83-85.
151. Perry AP. 1943. Chromosome number and phylogenetic relationship in the Euphorbiaceae. Am J Bot, 30:527-541.
152. Poltanov EA, Shikov AN, Dorman HJ, et al. 2009. Chemical and antioxidant evaluation of Indian gooseberry (Emblica officinalis Gaertn., syn. Phyllanthus emblica L.) supplements. Phytother Res, 23:1309-1315.
153. Pozharitskaya ON, Ivanova SA, Shikov AN, Makarov VG. 2007. Separation and evaluation of free radical scavenging activity of phenolic components of Emblica officinalis extract by using an HPTLC-DPPH method. J Sep Sci, 30:1250-1254.
154. Prakash D, Upadhyay G, Gupta C, Pushpangadan P, Singh KK. 2012. Antioxidant and free radical scavenging activities of some promising wild edible fruits. Int Food Res J, 19:1109-1116.
155. Pramyothin P, Samosorn P, Poungshompoo S, Chaichantipyuth C. 2006. The protective effects of Phyllanthus emblica Linn. extract on ethanol induced rat hepatic injury. J Ethnopharmacol, 107:361-364.
156. Priyadarsini K, Khopde S, Kumar S. 2000. Free radical studies of ellagic acid, a natural phenolic antioxidant. J Agric Food Chem, 50:2200-2206.
157. Raghu V, Patel K, Srinivasan K. 2007. Comparison of ascorbic acid content of Emblica officinalis fruits determined by different analytical methods. J Food Compos Anal, 20:529-533.
158. Raina K, Rajamanickam S, Deep G. 2008. Chemopreventive effects of oral gallic acid feeding on tumor growth and progression in TRAMP mice. Mol Cancer Ther, 7:1258-1267.
159. Rajeshkumar NV, Pillai MR, Kuttan R. 2003. Induction of apoptosis in mouse and human carcinoma cell lines by Emblica officinalis polyphenols and its effect on chemical carcinogenesis. J Exp Clin Cancer Res, 22:201-212.
160. Ram S, Raja T. 1978. Studies on naturally occurring gibberellins in aonla (Emblica officinalis) fruit. New Phytol, 81:513-519.
161. Ram S, Rao TR. 1976. Naturally occurring cytokinins in aonla (Emblica officinalis) fruit. New Phytol, 76:441-448.
162. Ramalho SA, Nigam N, Oliveira GB, Santos AGP, Narain N. 2012. Phenolic compounds present in Indian herbs. Proceedings ofIX Brazilian Meeting on Chemistry of Food and Beverages, 2-5 December 2012, Araraquara, Brazil.
163. Ramulu P, Rao PU. 2003. Total, insoluble and soluble dietary fiber contents of Indian fruits. J Food Compos Anal, 16:677-685.
164. Rawat RBS, Uniyal RC. 2003. Aonla: an important species for Indian systems of medicine. National Seminar on Production and Utilization of Aonla, 8-10 August, Salem, Tamil Nadu, India.
165. Reddivari L, Vanamala J, Safe S. 2009. The bioactive compounds alpha-chaconine and gallic acid in potato extracts decrease survival and induce apoptosis in LNCaP and PC3 prostate cancer cells. Nutr Cancer, 62:601-610.
166. Roy AK, Dhir H, Sharma A. 1992. Modification of metal- induced micronuclei formation in mouse bone marrow erythrocytes by Phyllanthus fruit extract and ascorbic acid. Toxicol Lett, 62:9-17.
167. Sabu MC, Kuttan R. 2002. Anti-diabetic activity of medicinal plants and its relationship with their antioxidant property. J Ethnopharmacol, 81:155-160.
168. Saeed S, Tariq P. 2007. Antibacterial activities of Emblica officinalis and Coriandrum sativum against Gram negative urinary pathogens. Pak J Pharm Sci, 20:32-35.
169. Saini A, Sharma S, Chhibber S. 2008. Protective efficacy of Emblica officinalis against Klebsiella pneumoniae induced pneumonia in mice. Ind J Med Res, 128:188-193.
170. Sai Ram M, Neetu D, Yogesh B, et al. 2002. Cyto-protective and immunomodulating properties of Amla (Emblica officinalis) on lymphocytes: an in-vitro study. J Ethnopharmacol, 81:5-10.
171. Saito K, Kohno M, Yoshizaki F, Niwano Y. 2008a. Antioxidant properties of herbal extracts selected from screening for potent scavenging activity against superoxide anions. J Sci Food Agric, 88:2707-2712.
172. Saito K, Kohno M, Yoshizaki F, Niwano Y. 2008b. Extensive screening for edible herbal extracts with potent scavenging activity against superoxide anions. Plant Foods Hum Nutr, 63:65-70.
173. Sakagami H, Jiang Y, Kusama K, Atsumi T, Ueha T, Toguchi M. 2000. Cytotoxic activity of hydrolysable tannins against human oral tumor cell lines: a possible mechanism. Phytomedicine, 7:39-47.
174. Sancheti G, Jindal A, Kumari R, Goyal PK. 2005. Chemopreventive action of Emblica officinalis on skin carcinogenesis in mice. Asian Pac J Cancer Prev, 6:197-201.
175. Sanchez-Perez Y, Carrasco-Legleu C, Garcia-Cuellar C, et al. 2005. Oxidative stress in carcinogenesis: correlation between lipid peroxidation and induction of preneoplastic lesions in rat hepatocarcinogenesis. Cancer Lett, 217:25-32.
176. Sandhya T, Lathika KM, Pandey BN, et al. 2006a. Protection against radiation oxidative damage in mice by Triphala. Mut Res, 609:17-25.
177. Sandhya T, Lathika KM, Pandey BN, Mishra KP. 2006b. Potential of traditional Ayurvedic formulation, Triphala, as a novel anticancer drug. Cancer Lett, 231:206-214.
178. Sandhya T, Mishra KP. 2006. Cytotoxic response of breast cancer cell lines, MCF 7 and T 47 D to Triphala and its modification by antioxidants. Cancer Lett, 238:304-313.
179. Sanjay K, Singh MK, Yadav SS, Gupta V. 2013. Immunomodulatory role of Emblica officinalis in arsenic induced oxidative damage and apoptosis in thymocytes of mice. BMC Comp Alt Med, 13:193-197.
180. Santoshkumar J, Manjunath S, Pranavkumar MS. 2013. A study of antihyperlipidemia, hypolipidemic and anti atherogenic activity of fruit of Emblica officinalis Gaertn (Euphorbiaceae). Phytomedicine, 10:583-589.
181. Sastry MV, Siddappa GS, Lal G. 1958. Chemical and microbial analysis of some important canned preserves. Ind J Hort, 15:26-31.
182. Saxena NC. 2003. Livelihood diversification and non timber forest products in Orissa: wider lessons in the scope for policy change? Working paper 223, Overseas Development Institute, London, UK.
183. Scartezzini P, Antognoni F, Raggi MA, Poli F, Sabbioni C. 2006. Vitamin C content and antioxidant activity of the fruit and of the Ayurvedic preparation of Emblica officinalis Gaertn. J Ethnopharmacol, 104:113-118.
184. Scartezzini P, Speroni E. 2000. Review on some plants of Indian traditional medicine with antioxidant activity. J Ethnopharmacol, 71:23-43.
185. Sengupta A, Ghosh S, Das S. 2001. Modulation of DMBA induced genotoxicity in bone marrow by quercetin during skin carcinogenesis. J Exp Clin Cancer Res, 20:131-134.
186. Senthil Kumar M, Kirubanandan S, Sripriya R, Sehgal PK. 2008. Triphala promotes healing of infected full thickness dermal wound. J SurgRes, 144:94-101.
187. Sharma N, Trikha P, Athar M, Raisuddin S. 2000a. Inhibitory effect of Emblica officinalis on the in vivo clastogenicity of benzo[a]pyrene and cyclophosphamide in mice. Hum Exp Toxicol, 19:377-384.
188. Sharma N, Trikha P, Athar M, Raisuddin S. 2000b. In vitro inhibition of carcinogen-induced mutagenicity by Cassia occidentalis and Emblica officinalis. Drug Chem Toxicol, 23:477-484.
189. Shukla AK, Samadia DK, Shukla AK, Dhandar DG. 2005. Genetic resources of aonla (Emblica officinalis Gaertn.). Indian J Plant Genet Resour, 18:188-193.
190. Singh IS, Pathak RK, Diwedi R, Singh HK. 1993a. Aonla production and post harvest technology. Department of Horticulture, N.D. University of Agriculture and Technology, Kumarganj, Faizabad, Uttar Pradesh, India.
191. Singh RB, Niaz MA, Ghosh S, Singh R, Rastogi SS. 1993b. Effect of mortality and reinfarction of adding fruits and vegetables to a prudent diet in the Indian experiment of infarct survival (IEIS). J Am Coll Nutr, 12:255-261.
192. Srikumar R, Parthasarathy NJ, Manikandan S, Narayanan GS, Sheela DR. 2006. Effect of Triphala on oxidative stress and on cell-mediated immune response against noise stress in rats. Mol Cell Biochem, 283:67-74.
193. Srikumar R, Parthasarathy NJ, Shankar EM, et al. 2007. Evaluation of the growth inhibitory activities of Triphala against common bacterial isolates from HIV infected patients. Phytother Res, 21:476-480.
194. Srirama R, Deepak HB, Senthilkumar U, et al. 2012. Hepatoprotective activity of Indian Phyllanthus. Pharm Biol, 50:948-953.
195. Sturrock D. 1959. Fruits of Southern Florida. South Eastern Printing: Stuart, FL, USA.
196. Sultana S, Ahmed S, Jahangir T. 2008. Emblica officinalis and hepatocarcinogenesis: a chemopreventive study in Wistar rats. J Ethnopharmacol, 118:1-6.
197. Sultana S, Ahmed S, Sharma S, Jahangir T. 2004. Emblica officinalis reverses thioacetamide-induced oxidative stress and early promotional events of primary hepatocarcinogenesis. J Pharm Pharmacol, 56:1573-1579.
198. Sumantran VN, Boddul S, Koppikar SJ, et al. 2007. Differential growth inhibitory effects of W. somnifera root and E. officinalis fruits on CHO cells. Phytother Res, 21:496-499.
199. Suresh K, Vasudevan DM. 1994. Augmentation of murine natural killer cell and antibody dependent cellular cytotoxicity activities by Phyllanthus emblica, a new immunomodulator. J Ethnopharmacol, 44:55-60.
200. Suryanarayana P, Saraswat M, Petrash JM, Reddy GB. 2007. Emblica officinalis and its enriched tannoids delay streptozotocin-induced diabetic cataract in rats. Mol Vis, 13:1291-1297.
201. Temple NJ. 2000. Antioxidants and disease: more questions than answers. Nutr Res, 20:449-459.
202. Thaweboon B, Thaweboon S. 2011. Effect of Phyllanthus emblica Linn. on candida adhesion to oral epithelium and denture acrylic. Asian Pac J Trop Med, 4:41-45.
203. Tripathi VK, Singh MB, Singh S. 1988. Studies on comparative compositional changes in different preserved products of Amla (Embilica officinalis Gaertn.) var. Banarasi. Indian Food Pac, 42:60-66.
204. Usharani P, Fatima N, Muralidhar N. 2013. Effects of Phyllanthus emblica extract on endothelial dysfunction and biomarkers of oxidative stress in patients with type 2 diabetes mellitus: a randomized, double blind controlled study. Diabetes Metab Syndr Obes, 6:275-284.
205. Vallyathan V. 2004. Oxidative stress/antioxidant status in health and disease. In: Vallyathan V, Shi X, Castranova V, Eds., Oxygen/Nitrogen Radicals: Lung Injury and Disease, pp. 35-58. Marcel Dekker: New York.
206. Varadacharyulu N, Reddy D, Padmavathi P, Paramhamsa M. 2009. Modulatory role of Emblica officinalis against alcohol induced biochemical and biophysical changes in rat erythrocyte membranes. Food Chem Toxicol, 47:1958-1963.
207. Veena K, Shanthi P, Sachdanandam P. 2006. The biochemical alterations following administration of Kalpaamruthaa and Semecarpus anacardium in mammary carcinoma. Chem Biol Interact, 161:69-78.
208. Veena K, Shanthi P, Sachdanandam P. 2007. Therapeutic efficacy of kalpaamruthaa on reactive oxygen/nitrogen species levels and antioxidative system in mammary carcinoma bearing rats. Mol Cell Biochem, 294:127-135.
209. Vijayababu M, Arunkumar K, Kanagaraj P. 2006. Quercetin downregulates matrix metalloproteinases 2 and 9 proteins expression in prostate cancer cells (PC-3). Mol Cell Biochem, 287:109-116.
210. Walle T, Walle U, Sedmera D. 2006. Benzo[a]pyrene- induced oral carcinogenesis and chemoprevention: studies in bioengineered human tissue. Drug Metab Dispos, 34:346-350.
211. Wang YF, Wang XY, Ren Z, et al. 2009. Phyllanemblinin B inhibits Coxsackie virus B3 induced apoptosis and myocarditis. Antivirus Res, 84:150-158.
212. Warrier PK, Nambiar VPK, Ramankutty C. 1996. Indian Medicinal Plants, vol. 5, pp. 225-228. Orient Longman: Hyderabad, India.
213. Webster GL. 1957. A monographic study of West Indian species of Phyllanthus. J Arn Arbor, 38:51-80.
214. Willett WC. 1994. Diet and health: what should we eat. Science, 254:532-537.
215. Willett WC. 1995. Diet, nutrition, and avoidable cancer. Environ Health Persp, 103:165-170.
216. Willett WC. 2002. Balancing life-style and genomics research for disease prevention. Science, 296:695-698.
217. Williams RO, Williams RO Jr. 1951. Useful and Ornamental Plants of Trinidad and Tobago, 4th edn. Guardian Commercial Printery: Port of Spain, Trinidad.
218. Yam S, Huang C, Wu S. 2010. Oleanolic acid and ursolic acid induce apoptosis in four human liver cancer cell lines. Toxicol In Vitro, 24:842-848.
219. Yang B, Kortesniemi M, Liu P, Karonen M, Salminen JP. 2012. Analysis of hydrolyzable tannins and other phenolic compounds in emblic leafflower (Phyllanthus emblica L.) fruits by high performance liquid chromatography-electrospray ionization mass spectrometry. J Agric Food Chem, 60:8672-8683.
220. Yang CJ, Wang CS, Hung JY, et al. 2009a. Pyrogallol induces G2-M arrest in human lung cancer cells and inhibits tumor growth in an animal model. Lung Cancer, 66:162-168.
221. Yang L, Jiang JG, Li WF, Chen J, Wang DY, Zhu L. 2009b. Optimum extraction process of polyphenols from the bark of Phyllanthus emblica L. based on the response surface methodology. J Sep Sci, 32:1437-1444.
222. Yasukawa K, Takido M, Matsumoto T. 1991. Sterol and triterpene derivatives from plants inhibit the effects of kaempferol on neoplastic cell transformation. Carcinogenesis, 31:1338-1343.
223. Yokozawa T, Kim HY, Kim HJ, et al. 2007a. Amla (Emblica officinalis Gaertn.) attenuates age-related renal dysfunction by oxidative stress. J Agric Food Chem, 55:7744-7752.
224. Yokozawa T, Kim HY, Kim HJ, Okubo T, Chu DC, Juneja LR. 2007b. Amla (Emblica officinalis Gaertn.) prevents dyslipidaemia and oxidative stress in the ageing process. Br J Nutr, 97:1187-1195.
225. You BR, Moon HJ, Han YH, Park WH. 2010. Gallic acid inhibits the growth of HeLa cervical cancer cells via apoptosis and/or necrosis. Food Chem Toxicol, 48:1334-1340.
226. Zhang LZ, Zhao WH, Guo YJ, Tu GZ, Lin S, Xin LG. 2003. Studies on chemical constituents in fruits of Tibetan medicine Phyllanthus emblica. Zhongguo Zhong Yao Za Zhi, 28:940-943.
227. Zhang X, Ling Y, Yu H. 2010. Studies on mechanism of myricetin-induced apoptosis in human hepatocellular carcinoma HepG-2 cells. Zhongguo Zhong Yao Za Zhi, 35:1046-1050.
228. Zhang YJ, Abe T, Tanaka T, Yang CR, Kouno I. 2001a. Phyllanemblinins A-F, new ellagitannins from Phyllanthus emblica. J Nat Prod, 64:1527-1532.
229. Zhang YJ, Nagao T, Tanaka T, Yang CR, Okabe H, Kouno I. 2004. Antiproliferative activity of the main constituents from Phyllanthus emblica. Biol Pharm Bull, 27:251-255.
230. Zhang YJ, Tanaka T, Yang C, Kouno I. 2001b. New phenolic constituents from the fruit juice of Phyllanthus emblica. Chem Pharm Bull 49:537-540.
231. Zhong ZG, Huang JL, Liang H, Zhong YN, Zhang WY, Wu DP. 2009. The effect of gallic acid extracted from leaves of Phyllanthus emblica and apoptosis of human hepatocellular carcinoma BEL-7404 cells. Zhong Yao Cai, 32:1097-1101.
232. Zhong Z, Wu D, Huang J, et al. 2011. Progallin A isolated from the acetic ether part of the leaves of Phyllanthus emblica L. induces apoptosis of human hepatocellular carcinoma BEL-7404 cells by up-regulation of Bax expression and down-regulation of Bcl-2 expression. J Ethnopharmacol, 133:765-772.